<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet type='text/xsl' href='https://www.exceedorphan.com/app/plugins/google-sitemap-generator/sitemap.xsl'?><!-- sitemap-generator-url='http://www.arnebrachhold.de' sitemap-generator-version='4.1.18' -->
<!-- generated-on='May 2, 2026 10:02' -->
<urlset xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd' xmlns='http://www.sitemaps.org/schemas/sitemap/0.9'>	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-unites-in-sopron-to-advance-rare-disease-patient-care/</loc>
		<lastmod>2025-09-25T08:33:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-supports-rare-disease-day/</loc>
		<lastmod>2025-02-27T12:10:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-new-member-of-the-management-team/</loc>
		<lastmod>2025-02-15T09:13:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-extension-of-an-exclusive-distribution-agreement-with-mirum-pharmaceuticals-for-marketing-and-distribution-of-livmarli-maralixibat-to-additional-cee-countries/</loc>
		<lastmod>2024-04-29T11:43:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-extension-of-an-exclusive-distribution-agreement-with-advicenne-for-marketing-and-distribution-of-sibnayal-in-estonia-latvia-and-lithuania/</loc>
		<lastmod>2024-04-29T11:42:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-opening-of-its-affiliate-in-poland/</loc>
		<lastmod>2024-04-29T11:41:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-extension-of-partnership-with-amryt-to-exclusively-distribute-lojuxta-in-17-countries-of-central-and-eastern-europe-cee/</loc>
		<lastmod>2024-04-29T11:41:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/neobiomics-ab-and-exceed-orphan-s-r-o-announce-an-extended-partnership-for-proprems-in-estonia-latvia-and-lithuania/</loc>
		<lastmod>2022-11-21T08:18:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-new-members-of-the-team-in-several-countries-of-the-cee-region/</loc>
		<lastmod>2022-11-21T08:13:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/rafa-laboratories-to-acquire-a-significant-stake-in-exceed-orphan-and-expand-its-international-capabilities-in-medicines-addressing-rare-diseases/</loc>
		<lastmod>2024-06-06T06:55:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-new-member-of-the-eo-management-team/</loc>
		<lastmod>2022-07-18T09:12:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-partnership-with-amryt-to-exclusively-distribute-filsuvez-in-central-and-eastern-europe-cee/</loc>
		<lastmod>2022-07-13T07:44:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-partnership-with-serb-to-exclusively-distribute-voraxaze-and-digifab-in-central-and-eastern-europe-cee/</loc>
		<lastmod>2022-05-11T07:59:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-opening-of-the-third-non-eu-affiliate-in-albania/</loc>
		<lastmod>2022-05-11T07:53:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-proveca-pharma-ltd-partnership/</loc>
		<lastmod>2022-03-09T07:59:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/first-sales-of-proprems-in-the-cee-region/</loc>
		<lastmod>2022-02-01T10:29:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-new-members-of-the-team-in-adriatic-region/</loc>
		<lastmod>2022-01-31T14:09:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-signature-of-an-exclusive-distribution-agreement-with-advicenne-for-marketing-and-distribution-of-sibnayal-in-central-and-eastern-europe/</loc>
		<lastmod>2021-12-07T10:59:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-opening-of-the-next-non-eu-affiliate-in-north-macedonia/</loc>
		<lastmod>2021-12-02T10:37:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-and-world-orphan-drug-congress-in-barcelona/</loc>
		<lastmod>2021-11-16T14:40:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-signature-of-distribution-agreement-with-komtur-pharmaceuticals-for-czech-republic-poland-and-slovakia/</loc>
		<lastmod>2021-11-01T10:47:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-signature-of-an-exclusive-distribution-agreement-with-diurnal-for-marketing-and-distribution-of-alkindi-and-efmody-in-central-and-eastern-europe-2/</loc>
		<lastmod>2021-11-01T10:47:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-signature-of-an-exclusive-distribution-agreement-with-diurnal-for-marketing-and-distribution-of-alkindi-and-efmody-in-central-and-eastern-europe/</loc>
		<lastmod>2021-10-14T09:31:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-opening-of-its-first-non-eu-affiliate-in-serbia/</loc>
		<lastmod>2021-10-05T08:12:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-s-r-o-announces-cooperation-with-mytomorrows-for-selected-central-and-eastern-european-countries/</loc>
		<lastmod>2021-09-17T10:32:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/neobiomics-ab-and-exceed-orphan-s-r-o-announce-exclusive-cooperation-for-central-and-eastern-europe/</loc>
		<lastmod>2021-05-21T11:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-features-in-pharma-tech-outlooks-top-10-marketing-service-companies-in-europe/</loc>
		<lastmod>2021-05-12T08:41:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-s-r-o-announces-joining-your-pharma-partner-in-europe-network-as-of-may-1-2021/</loc>
		<lastmod>2021-04-30T12:34:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-new-members-of-the-team-in-poland/</loc>
		<lastmod>2021-04-02T08:32:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-today-the-launching-of-its-distribution-capacity/</loc>
		<lastmod>2021-03-11T11:34:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/rare-disease-day-support-2/</loc>
		<lastmod>2021-02-16T14:32:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-new-member-of-the-team/</loc>
		<lastmod>2021-02-16T14:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-continues-cooperation-with-novartis-gene-therapies-for-zolgensma/</loc>
		<lastmod>2020-12-23T11:25:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-new-members-of-the-team/</loc>
		<lastmod>2020-12-23T12:59:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-starts-cooperation-with-hansa-biopharma/</loc>
		<lastmod>2020-12-23T13:05:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-its-cooperation-with-pharming/</loc>
		<lastmod>2020-12-23T11:22:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-signed-cooperation-with-ernst-young/</loc>
		<lastmod>2020-12-23T11:17:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-extends-cooperation-with-kyowa-kirin/</loc>
		<lastmod>2020-12-23T11:14:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-its-cooperation-with-neox-company/</loc>
		<lastmod>2020-12-23T11:13:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-new-organizational-structure-and-related-appointments/</loc>
		<lastmod>2020-08-12T10:16:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-announces-opening-of-the-first-foreign-affiliate-in-croatia/</loc>
		<lastmod>2020-07-08T03:50:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-cooperation-with-kyowa-kirin-extended-for-romania/</loc>
		<lastmod>2020-07-08T07:25:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-initiates-cooperation-with-novartis-hungary-for-zolgensma/</loc>
		<lastmod>2020-07-08T07:25:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-continues-cooperation-with-avexis-for-zolgensma/</loc>
		<lastmod>2020-07-08T07:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/avexis-receives-ec-approval-for-zolgensma/</loc>
		<lastmod>2020-05-19T12:31:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/gene-therapy-reimbursed-for-sma-patients-in-czechia-2/</loc>
		<lastmod>2020-05-15T17:25:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/gene-therapy-reimbursed-for-sma-patients-in-czechia/</loc>
		<lastmod>2020-05-15T17:19:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/eurodis-and-covid-19-pandemic/</loc>
		<lastmod>2020-05-18T07:43:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/kyowa-kirin-cooperation-extended/</loc>
		<lastmod>2020-05-15T16:21:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/avexis-receives-positive-chmp-opinion-for-zolgensma/</loc>
		<lastmod>2020-05-15T17:20:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/novartis-receives-approval-from-japanese-ministry-of-health-labour-and-welfare-for-zolgensma-2/</loc>
		<lastmod>2020-05-15T17:20:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/rare-disease-day-support/</loc>
		<lastmod>2020-02-28T19:00:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/cooperation-with-kyowa-kirin/</loc>
		<lastmod>2020-01-07T13:46:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/further-cooperation-with-akcea/</loc>
		<lastmod>2020-01-07T13:37:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/avexis-receives-fda-approval-for-zolgensma/</loc>
		<lastmod>2020-01-07T13:44:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/akcea-and-ionis-announce-approval-of-waylivra/</loc>
		<lastmod>2020-01-07T13:43:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/cooperation-with-avexis/</loc>
		<lastmod>2020-01-07T13:36:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/cooperation-with-akcea/</loc>
		<lastmod>2020-01-07T13:39:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://www.exceedorphan.com/exceed-orphan-established/</loc>
		<lastmod>2020-01-07T13:30:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
</urlset><!-- Request ID: 3b8136fdefd03525fa6509fc77141971; Queries for sitemap: 5; Total queries: 32; Seconds: $end_time; Memory for sitemap: 0MB; Total memory: 66MB -->
